Patents by Inventor Tung-Hu Tsai

Tung-Hu Tsai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9144414
    Abstract: The present invention relates to a method for quantifying drug delivery with the characteristic of measuring the signal intensity of peripheral vessels with a contrast-enhanced ultrasound to quantify the drug delivery at a target site. The present invention can be used for quantifying UTMD (ultrasound triggered microbubble destruction) targeted drug delivery, also for qualifying the unreleased amount of the long-acting drug in the tested object, and for helping setting the treatment schedule for ultrasound disruption of blood-brain barrier.
    Type: Grant
    Filed: May 2, 2012
    Date of Patent: September 29, 2015
    Assignee: Taipei City Hospital
    Inventors: Shuo-Hui Hung, Ran-Chou Chen, Tung-Hu Tsai
  • Publication number: 20130116569
    Abstract: The present invention relates to a method for quantifying drug delivery with the characteristic of measuring the signal intensity of peripheral vessels with a contrast-enhanced ultrasound to quantify the drug delivery at a target site. The present invention can be used for quantifying UTMD (ultrasound triggered microbubble destruction) targeted drug delivery, also for qualifying the unreleased amount of the long-acting drug in the tested object, and for helping setting the treatment schedule for ultrasound disruption of blood-brain barrier.
    Type: Application
    Filed: May 2, 2012
    Publication date: May 9, 2013
    Inventors: Shuo-Hui HUNG, Ran-Chou Chen, Tung-Hu Tsai
  • Patent number: 8183297
    Abstract: The invention relates to a device for selecting stem cells with a serum free medium for amplification of stem cells. The invention also relates to a method of treating or preventing diseases caused by cancer-related stem cells. The invention further provides a method of enhancing radiosensitivity of cancer-related stem cells comprising radiotherapy with resveratrol, and the cancer-related stem cell has stronger drug resistance. The present invention further provides that resveratrol promotes differentiation and inhibits teratoma/tumor formation in induced pluripotent stem cells (iPS) and embryonic stem cells.
    Type: Grant
    Filed: July 10, 2009
    Date of Patent: May 22, 2012
    Assignee: Taipei Veterans General Hospital
    Inventors: Shih-Hwa Chiou, Tsung-Yun Liu, Tung-Hu Tsai, Jeng-Fan Lo, Yi-Ping Yang, Fu-Ting Tsai, Yu-Chih Chen, Chian-Shiu Chien
  • Publication number: 20100010099
    Abstract: The invention relates to a device for selecting stem cells with a serum free medium for amplification of stem cells. The invention also relates to a method of treating or preventing diseases caused by cancer-related stem cells. The invention further provides a method of enhancing radiosensitivity of cancer-related stem cells comprising radiotherapy with resveratrol, and the cancer-related stem cell has stronger drug resistance.
    Type: Application
    Filed: July 10, 2009
    Publication date: January 14, 2010
    Applicant: TAIPEI VETERANS GENERAL HOSPITAL
    Inventors: SHIH-HWA CHIOU, TSUNG-YUN LIU, TUNG-HU TSAI, JENG-FAN LO, YI-PING YANG, FU-TING TSAI, YU-CHIH CHEN, CHIAN-SHIU CHIEN
  • Publication number: 20090105562
    Abstract: The present invention relates to the system and methods for screening or analyzing targets.
    Type: Application
    Filed: October 19, 2007
    Publication date: April 23, 2009
    Applicant: TAIPEI VETERANS GENERAL HOSPITAL
    Inventors: Shih-Hwa Chiou, Tung-Hu Tsai, Yuh-Lih Chang, Chih-Ju Yen